Is Lazard the next Greenhill?

Following this article, I'm really wondering whether they're about to be sold/merged... At this point, they are really relying on their brand legacy, similarly to Greenhill

https://www.ft.com/content/cc892654-6d14-4036-8474-a1cbbfba532a

24 Comments
 

No surprise at all if they will. Lazard has been underperforming over the last decade or so. Still a good place, but definitely below the top EBs, or even a place like Moelis that has a much better growth trajectory

 

quality of transactions, no. offices/employees, general perception of MOE vs LAZ

 

Yes, Lazard is no longer an elite EB, it's a failing bank, especially in NA. It's the weakest EB if you don't count something like Guggenheim due to it's growth trajectory. PJT overall is still stronger due to RX

 
Most Helpful

Weaker growth trajectory, and even take a look at YTD deals across M&A and rx. PWP fraction of headcount and higher on league tables, and Moelis and PWP have been killing it in rx this year. Lazard used to the the dominant debtor side player, not the case anymore, ask anyone still working there. PJT/EVR now in that spot.

I’m not going to go as far as saying “Lazard is the new GHL”, totally different situations. Lazard is institutionalized at this point and much stronger globally, GHL never grew and paid the price as key figures left/retired etc.

 

Candidly where are they on the league tables anymore? Lazard is a relic. When you consider Lazard’s business model (far more institutionalized, almost an Evercore lite) they should be much higher up than they are especially relative to headcount. PWP has like 650-700 employees and is somehow higher than them. I don’t think it’s particularly a reflection of Moelis and PWP being better as much as it is Lazard just being that much worse now.

 

Ken Jacobs tried to cover up a stagnant IB business by investing in the asset management business.  Which isn't a solution, so he eventually "stepped down" which is one way of saying it.

The new CEO Orszag could be better but I'm skeptical. He's never really been a banker in my mind. Was a government guy, then took one of of those dignitary roles that EBs love (Moelis has Eric Cantor, PJT had David Stern, Lazard had Vernon Jordan and Orszag). So he was nominally a healthcare banker but certainly wasn't out there coming up with strategic alternatives like a proper coverage MD. No business background. To make that guy CEO seems questionable, and the exact sort of questionable move Lazard makes. They're always trying to pretend winning IB business is about belonging to the right clubs rather than hustling for business.

 

If you mean that they are like Greenhill because of the way they fell relative to their peak, then you're not wrong. Everyone in the industry pretty much acknowledges that they aren't what they used to be. Still a decent firm, but lost a lot of its glamour from the old days. Plus, at this point they have become way too institutionalized (which comes with its own negatives, like abundance of diversity hires who, for the most part, are a pain in the ass).

To be frank, I'm not sure what happened with Lazard. Greenhill's downfall story is pretty straightforward - they simply refused to grow when others did, expanding their coverage and advisory capabilities. As with Lazard, I'd say that it just became very top heavy with a bunch of inflated ego types that drove away a lot of the successful rainmarkers over the years to the likes of EVR, CVP etc

 

Interesting take on Greenhill. Would you say Centerview having the same fate in a decade or so? After all, they're also sticking to remaining a small advisory firm with no intention to expand

 

looks like it, judging by its share price and its talks last year to get acquired by a SWF

 

Totam soluta cumque laboriosam non sit ipsam. Ab enim optio suscipit.

Consequatur in deserunt error et veniam et ea. Harum cumque minima rerum atque sed veritatis.

Eligendi perspiciatis temporibus sint quibusdam porro ad quae. Inventore dolore quis cum. Et necessitatibus quae voluptatem exercitationem magnam dolorum. In iste enim optio ut qui id possimus quis. Repellat et harum vel officia id id temporibus.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”